Speech-Language Pathologists in Escanaba, MI Accepting Medicare

6 Speech-Language Pathologists found. Showing 1 - 6

Laura Kae Mead, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3401 Ludington St, Escanaba, MI 49829 Phone: 906-233-4141

Hunter Branstrom-kleiman Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2525 3rd Ave S, Escanaba, MI 49829 Phone: 906-786-9300

Mrs. Erika Ann Larson, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2510 1st Ave N, Suite 2, Escanaba, MI 49829 Phone: 906-399-7402

Julie Aschbacher Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3401 Ludington St, Escanaba, MI 49829 Phone: 906-233-4141

Danielle Dee Way, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3401 Ludington St, Escanaba, MI 49829 Phone: 906-233-4141

Mrs. Amber Joy Quigley, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Willow Creek Road, Escanaba, MI 49829 Phone: 906-233-4141

News Archive

Experiments explain factors behind common malarial symptoms

When people have malaria, they are infected with Plasmodium parasites, which enter the body from the saliva of a mosquito, infect cells in the liver, and then spread to red blood cells. Inside the blood cells, the parasites replicate and also begin to expose adhesive proteins on the cell surface that change the physical nature of the cells in the bloodstream.

CRAB CTC enrolls first patient into inaugural cancer clinical trial

Cancer Research And Biostatistics today announced enrollment of the first patient into the inaugural clinical trial sponsored by its Clinical Trials Consortium. The CRAB CTC mission is to ensure rapid clinical testing of new and innovative cancer treatments, and is focusing on lung cancer as its first target. By engaging frontline treating oncologists to push the boundaries of patient care, the aim is to improve the standard of care and extend overall survival.

Study finds excessive mortality in people with extremely high levels of good cholesterol

It has been accepted wisdom for many years that the more good cholesterol people have in their blood, the better. But the good cholesterol, also known as HDL, might not be as good as we think.

New technologies could aid in malignant melanoma diagnosis and therapy

Because the incidence of malignant melanoma is rising faster than any other cancer in the U.S., researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues at Tampa-based Intezyne Technologies, Inc., Western Carolina University and the University of Arizona are working overtime to develop new technologies to aid in both malignant melanoma diagnosis and therapy.

Read more Medical News

› Verified 1 days ago